Has a total of 5 pipelines: 2 clinical, 1 preclinical and 2 discovery-stage.
First written in FY2024. 3 of 5 entries say "Restated". Latest entry: 2026-10-15.
No other company in this theme has enough history to compare yet.
- 2026-10-15RestatedEarnings
「We are advancing research and development of 5 pipelines centered on the CLK inhibitor CTX-712, whose international nonproprietary name is rogocekib (hereinafter, “rogocekib”).」
rogocekibを中心とする5つのパイプラインを保有し、研究開発を進める構成が再確認された。 - FY2026-H1RestatedAnnual report
「We are advancing research and development of 5 pipelines centered on the CLK inhibitor CTX-712, whose international nonproprietary name is rogocekib (hereinafter, “rogocekib”).」
The company continues to hold 5 pipelines centered on rogocekib and is advancing research and development. - FY2025AdvancedAnnual report
「We currently have 2 clinical pipelines (the CLK inhibitor CTX-712, whose international nonproprietary name is rogocekib (hereinafter, “rogocekib”), and the MALT1 inhibitor CTX-177 (hereinafter, “CTX-177”)) and 3 preclinical pipelines (the CDK12 inhibitor CTX-439 (hereinafter, “CTX-439”), the GCN2 inhibitor and a new pipeline), for a total of 5 pipelines (Figure 3).」
The company continues to have 5 pipelines, including 3 preclinical pipelines, of which CTX-439 is in the preclinical research stage and the other 2 are in the discovery research stage. - FY2025-H1RestatedAnnual report
「Against this backdrop, research and development of the 5 pipelines, centered on the CLK inhibitor CTX-712, whose international nonproprietary name is rogocekib (hereinafter, “rogocekib”), progressed smoothly during the interim accounting period.」
The company continues to hold 5 pipelines centered on rogocekib and is advancing research and development. - FY2024First statedAnnual report
「We currently have 2 clinical pipelines (the CLK inhibitor and MALT1 inhibitor), 1 preclinical pipeline (the CDK12 inhibitor), and 2 discovery-stage pipelines (the GCN2 inhibitor and a new pipeline), for a total of 5 pipelines.」
The composition and total number of pipelines by development stage were disclosed.